BioLife Solutions Price to Free Cash Flow Ratio 2010-2024 | BLFS

BioLife Solutions price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as

BioLife Solutions Price to Free Cash Flow Ratio 2010-2024 | BLFS

BioLife Solutions price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$205.5B
Stryker (SYK)$138.7B
Boston Scientific (BSX)$121.5B
Medtronic (MDT)$113.7B
EssilorLuxottica (ESLOY)$104.2B
Haleon (HLN)$48.6B
Lonza Group Ag (LZAGY)$45.9B
ResMed (RMD)$36.9B
Koninklijke Philips (PHG)$29.3B
Terumo (TRUMY)$27.8B
Zimmer Biomet Holdings (ZBH)$21.6B
Baxter (BAX)$20.3B
Insulet (PODD)$16.5B
Smith & Nephew SNATS (SNN)$13.5B
Bio-Rad Laboratories (BIO)$9.3B
Demant (WILYY)$9.2B
BellRing Brands (BRBR)$7.7B
Lantheus Holdings (LNTH)$7.3B
ICU Medical (ICUI)$4.3B
Haemonetics (HAE)$3.9B
TG Therapeutics (TGTX)$3.9B
GN Store Nord (GNNDY)$3.8B
Perrigo (PRGO)$3.8B
Neogen (NEOG)$3.7B
Prestige Consumer Healthcare (PBH)$3.6B
Envista Holdings (NVST)$3.3B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Maravai LifeSciences Holdings (MRVI)$2.3B
Green Thumb Industries (GTBIF)$2.2B